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Osteoclast maturation and function primarily depend
on receptor activator of NF-kB ligand (RANKL)-medi-
ated induction of nuclear factor of activated T cells c1
(NFATc1), which is further activated via increased
intracellular calcium ([Ca2+]i) oscillation. However,
the coordination mechanism that mediates Ca2+
oscillation during osteoclastogenesis remains ill
defined. Here, we identified transmembrane protein
64 (Tmem64) as a regulator of Ca2+ oscillation during
osteoclastogenesis. We found that Tmem64-defi-
cient mice exhibit increased bone mass due in part
to impaired osteoclast formation. Using in vitro oste-
oclast culture systems, we show here that Tmem64
interacts with sarcoplasmic endoplasmic reticulum
Ca2+ ATPase 2 (SERCA2) and modulates its activity.
Consequently, Tmem64 deficiency significantly
diminishes RANKL-induced [Ca2+]i oscillation, which
results in reduced Ca2+/calmodulin-dependent
protein kinases (CaMK) IV and mitochondrial ROS,
both of which contribute to achieving the CREB
activity necessary for osteoclast formation. These
data demonstrate that Tmem64 is a positive modu-
lator of osteoclast differentiation via SERCA2-depen-
dent Ca2+ signaling.
INTRODUCTION
Skeletal bone is maintained via continuous bone formation and
destruction mediated by osteoblasts and osteoclasts (Zaidi,
2007; Zelzer and Olsen, 2003). Imbalance of bone homeostasis
causes various skeletal disorders (Teitelbaum and Ross, 2003).
Congenital defects in the development and function of osteo-
clasts lead to osteopetrosis, which is characterized by high
bone mineral density. In contrast, excessive osteoclast differen-Cell Mtiation and activity causes osteoporosis, or low bone mineral
density. Therefore, investigations of osteoclast differentiation
and function aim to reveal the physiology and pathology of the
skeletal system and to provide a molecular basis for designing
therapeutic strategies for bone remodeling diseases (Karsenty
and Wagner, 2002).
Since the discovery of RANKL as an essential osteoclast
differentiation factor, many of the signaling pathways required
for RANKL-induced osteoclast differentiation have been
identified (Walsh et al., 2006). Binding of RANKL to RANK
triggers TRAF6-dependent signaling, activating NF-kB, Akt,
and MAP kinases (ERK, JNK, and p38). In other pathways,
immunoreceptor tyrosine-based activation motif (ITAM)-bearing
adaptors, Fc receptor common g subunit (FcRg) and DNAX-acti-
vating protein 12 (DAP12) deliver costimulatory signals through
activation of PLCg. Activated PLCg leads to the generation of
inositol-1,4,5-triphosphate (IP3), which mobilizes Ca
2+ from
the ER stores through inositol triphosphate receptors (IP3Rs)
(Ferron et al., 2011; Kim et al., 2002; Koga et al., 2004; Kuroda
et al., 2008), and subsequently generates Ca2+ oscillation,
which is critical for the activation of CaMKIV and NFATc1. This
RANKL-induced Ca2+ oscillation activates Ca2+/calmodulin-
dependent protein kinases (CaMK)IV, followed by cAMP-
responsive element binding protein (CREB) activation (Sato
et al., 2006), which is also induced by mitochondrial reactive
oxygen species (ROS) (Ishii et al., 2009). The CaMKIV/CREB/
NFATc1 pathway is critical to osteoclast differentiation and
function (Negishi-Koga and Takayanagi, 2009). Although Ca2+
oscillations are important triggers for efficient activation of
NFATc1, the intra- and/or extracellular pathways that regulate
Ca2+ oscillations during osteoclast differentiation are less well
understood.
Sarco/endoplasmic reticulum Ca2+-ATPases (SERCAs) are
a family of proteins reported to be involved in Ca2+ homeostasis
in a broad range of cells (Feske, 2007; Fu et al., 2011). SERCA
proteins are encoded by a multigenic family that includes
SERCA13 (Atp2a13). Each gene encodes at least five splicing
isoforms. SERCA1a and SERCA1b aremainly expressed in adult
and neonatal fast-twitch skeletal muscles, whereas SERCA2a isetabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inc. 249
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extension, is ubiquitously expressed in smooth muscle tissues
and nonmuscle tissues, including neurons. SERCA3 also has
various 30-end splice variants and limited expression in non-
muscle tissues (Dally et al., 2006). Recent studies have revealed
that a number of proteins, such as ER protein 57 (also known
as 1,25-MARRS, ERp57, ERp60, GRP58, or Pdia3) (Li and
Camacho, 2004), calreticulin (John et al., 1998), sarcalumenin
(Shimura et al., 2008), histidine-rich Ca2+-binding protein (HRC)
(Arvanitis et al., 2007), and calumenin (Sahoo et al., 2009), asso-
ciate with and regulate SERCA2b stability and activity, but the
mechanisms are not completely understood. It has recently
been reported that SERCA2 heterozygosity (SERCA2+/) causes
defects in osteoclast differentiation because of suppressed
RANKL-induced [Ca2+]i oscillations, and is associated with
bone abnormalities (Yang et al., 2009).
In this study, we report that Tmem64 is a regulator for RANKL-
mediated Ca2+ signaling pathways via its direct association with
SERCA2, which is critical for the RANKL-induced CREB activa-
tion and mitochondrial ROS generation necessary for proper
osteoclast generation.
RESULTS
Tmem64 Deletion Increases Bone Mass in Mice
We have previously reported that ablation of the d2 isoform of
vacuolar (H+) ATPase (v-ATPase) V0 domain (Atp6v0d2) in
mice produces osteopetrotic bone morphogenesis due to
impaired osteoclast fusion and enhanced bone formation (Lee
et al., 2006). To understand the molecular bases of Atp6v0d2/
osteoclast defects, we analyzed gene expression in wild-type
(WT) and Atp6v0d2/ osteoclast precursors using global
mRNA profiles. Surprisingly, we found that only one gene, trans-
membrane protein 64 (Tmem64), exhibited markedly increased
expression in RANKL-stimulated Atp6v0d2-deficient osteoclast
precursors. Tmem64 mRNA is detected in various tissues (Fig-
ure S1A available online), its expression is upregulated during
RANKL-induced osteoclastogenesis in vitro, and siRNA knock-
down of Tmem64-inhibited osteoclast formation (Figure S1B).
These findings suggest that increased Tmem64 expression in
Atp6v0d2/ BMMs is not likely responsible for defects in
Atp6v0d2/ osteoclasts and that Tmem64 expression may
not be regulated directly by Atp6v0d2. Although this result disin-
clined further examination of an explicit relationship between
Tmem64 and Atp6v0d2, we believed the unique expression
profile and siRNA effects of Tmem64 merited additional exami-
nation with respect to potential function(s) in the context of oste-
oclast biology.
To identify the in vivo function of Tmem64 in bone remodeling,
we generated Tmem64 knockout mice using embryonic stem
(ES) cells with a disruption of the Tmem64 gene (Figure 1A,
left panel). Specific deletion of Tmem64 genomic DNA was
confirmed by Southern blotting (Figure 1A, middle panel) and
sequencing; mouse genotypes were verified by PCR (Figure 1A,
right panel) and sequencing analysis (data not shown). Eight
weeks after birth, Tmem64/mice showed normal appearance
and growth, and most tissues exhibited no differences between
groups. However, bone microstructure imaging by high-resolu-
tion microcomputed tomography (mCT) of Tmem64/ mice250 Cell Metabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inrevealed significantly increased bone mass, characterized by
augmented bone indices including bone mineral density
(BMD), bone mineral content (BMC), trabecular bone volume
per tissue volume (BV/TV), trabecular thickness (Tb.Th), and
trabecular number (Tb.N), with concomitant decrease in trabec-
ular spacing (Tb.Sp) (Figure 1B). Increased bone volume was
observed starting at 6 weeks of age (Figure S1C). Bone sections
with von Kossa staining also showed increased trabecular bone
surface in Tmem64/ versus WT mice (Figure 1C, left panel).
Tartrate-resistant acidic phosphatase (TRAP)-stained bone
sections exhibited a reduction in osteoclast numbers and osteo-
clast surface size in Tmem64/ versus WT (Figure 1C, right
panel). Serum TRACP-5b, an early marker of osteoclast forma-
tion, was consistently reduced in mutant mice (Figure 1D). Along
with reduced in vitro osteoclast formation by Tmem64 knock-
down (Figure S1B), these results suggested a potential link
between Tmem64 ablation and an intrinsic defect in osteoclast
differentiation. By contrast, Tmem64/ mice showed marked
increases in osteoblast surface area, bone formation rates
(Figures 1C and 1E), and serum osteocalcin (Figure 1F).
Tmem64 expression is downregulated during osteoblast
differentiation (Figure S2A). In vitro osteogenic differentiation
increased in Tmem64/ calvaria-derived osteoblast precursors
versus WT, as verified by increased activity of alkaline phospha-
tase (ALP) and visualized by alizarin red staining for mineralized
nodule formation and calcium deposits (Figure S2B). This was
also confirmed by upregulation of osteoblast marker genes,
such as ALP, collagen type I (Col1a), osteocalcin (OCN),
Runx2, osterix (Osx), osteoprotegrin (Tnfrsf11b), colony stimu-
lating factor 1 (Csf1), and RANKL (Tnfsf11), and by enhanced
activity of b-catenin in Tmem64/ osteoblasts (as assessed
by crossing to the BAT-GAL b-catenin reporter mouse) (Figures
S2C and S2D). We have thus obtained strong genetic evidence,
using Tmem64/ mice, that Tmem64 is a regulator of bone
metabolism; its absence results in reduced osteoclast numbers
and increased bone formation in vivo. Although Tmem64
appears to affect both osteoclasts and osteoblasts, we have
initially focused on dissecting the role of Tmem64 in osteoclast
differentiation because we currently have a better understanding
of the molecular pathways controlled by RANKL stimulation (and
its attendant effects) when using a relatively homogenous popu-
lation of bone marrow (BM)-derived osteoclast precursor cells.
Tmem64 Positively Regulates Osteoclast
Differentiation
Our analysis of Tmem64/ versus WT bones clearly showed
reduced osteoclast numbers in vivo. Preliminary data for
Tmem64 siRNA suggested that Tmem64 knockdown reduced
RANKL-induced osteoclast generation. However, osteoclast
defects in Tmem64/ mice may have been due to crosstalk
with abnormal Tmem64/ osteoblasts. Therefore, it was neces-
sary to determine (1) whether there were cell-intrinsic defects in
the absence of Tmem64 during RANKL-induced osteoclast
generation, and (2) at which stage(s) of osteoclast differentiation
Tmem64/ defects manifest. To determine the intrinsic cellular
role of Tmem64 in osteoclast generation, we employed a stan-
dard in vitro osteoclast culture method using M-CSF and
RANKL: bone marrow macrophages (BMMs) were generated
by culturing BM cells with M-CSF only and Tmem64 knockoutc.
Figure 1. Ablation of Tmem64 Enhances Bone Density in Mice
(A) Generation of Tmem64 knockout mice (left panel). E, EcoRI; TRAP cassette (Neo/b-galactosidase); SA, splice acceptor; pA, polyadenylation sequence.
Homologous recombination was confirmed by Southern blot analysis of EcoRI-digested genomic DNA with a 30 region probe (middle panel). PCR genotyping
analysis of Tmem64+/+, Tmem64+/, and Tmem64/ mice (right panel).
(B) Microcomputed tomography (mCT) images of the proximal femur from WT and Tmem64/ mice (top, axial view of the metaphyseal region; bottom, longi-
tudinal view). BV/TV, trabecular bone volume per tissue volume; Tb.Th, trabecular thickness; BMD, bone mineral density; Tb.N, trabecular number; Tb.Sp,
trabecular spacing; BMC, bone mineral content. Scale bar represents 1 mm.
(C) Histological analysis of tibias from 8-week-old WT and Tmem64/ mice. Tibial sections were stained with Toluidine blue (left panels), von Kossa (middle
panels), or for TRAP (right panels). N.Oc/BS, osteoclast number per bone surface; Oc.S/BS, osteoclast surface per bone surface; Ob.S/BS, osteoblast surface
per bone surface; BV/TV, bone volume per tissue volume. Scale bar represents 50 mm.
(D) Serum TRAP-5b abundance in WT and Tmem64/ mice.
(E) Dynamic histomorphometry of tibia from 8-week-old WT and Tmem64/ mice. MS/BS, mineralizing surface per bone surface; BFR, bone formation
(per trabecular surface); MAR, mineral apposition rate. Scale bar represents 10 mm.
(F) Serum osteocalcin abundance in WT and Tmem64/mice. *p < 0.01, **p < 0.05 between the indicated groups. NS, not significant. Data are represented as
mean ± SD. See also Figures S1 and S2.
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then, BMMs were induced to differentiate into osteoclasts by
RANKL. When purified BM cells were induced to become oste-
oclasts, Tmem64 mRNA levels increased (Figure 2A, right panel;
real-time PCR and RT-PCR), and Tmem64/ BMMs stimulated
with RANKL exhibited significantly fewer TRAP+ multinucleated
cells (MNCs), considered to be mature osteoclasts, in compar-
ison to WT BMMs (Figure 2B). Moreover, Tmem64/ BMMsCell Mshowed impaired osteoclast generation whether they were
cocultured with WT or Tmem64/ osteoblasts (Figure S1D),
and independent of RANKL expression levels (Figure S2E).
These results strongly suggest that Tmem64 expression in oste-
oclast lineages is required for proper osteoclast differentiation.
We also revealed that levels of NFATc1, OSCAR, ctsk, and
ppargc1b, which are markers of differentiated osteoclasts,
were significantly lower in Tmem64/ cells (Figure 2C), whereasetabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inc. 251
Figure 2. Tmem64 Deficiency Inhibited
Osteoclastogenesis and Bone Resorption
(A) Northern blot analysis of Tmem64 mRNA in
BMMs from WT and Tmem64/ mice (left panel),
and real-time PCR (right upper) and conventional
RT-PCR (right lower) of Tmem64 mRNA expres-
sion during osteoclast differentiation.
(B) Osteoclast differentiation of the WT and
Tmem64/ cells. Right shows the number of
TRAP+ MNCs. Scale bar represents 100 mm.
(C) Expression of osteoclast marker genes during
osteoclastogenesis. Total RNA was collected on
the indicated days and subjected to real-time
PCR.
(D) The percent frequency of a population of
osteoclast precursor cells (c-Fms+c-Kir+Mac-1low)
is shown as the mean ± SD.
(E) Proliferation was assessed by the absorbance
of incorporated BrdU in WT and Tmem64/
BMMs.
(F) Caspase-3 activity was measured in mature
osteoclasts.
(G) Bone resorption activity of WT and Tmem64/
osteoclast. After differentiation of BMMs into
osteoclasts on dentine slices, cells were stained
with the TRAP Kit and pit area was analyzed. Scale
bar represents 200 mm. *p < 0.01 between the
indicated groups. NS, not significant. Data are
represented as mean ± SD.
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cells (Figure S3A). The proportion of osteoclast precursor cells
(c-Fms+c-Kit+Mac-1low) to the total number of bonemarrow cells
was equivalent in WT and Tmem64/mice (Figure 2D). Prolifer-
ation and apoptosis of osteoclasts in vitro inWT and Tmem64/
cells were also comparable (Figures 2E and2F). In addition,when
cultured on dentine slices, the pit area formed from Tmem64/
BMMs was small, but no difference in the pit area per osteoclast
size was observed (Figure 2G). These results suggest that
Tmem64 is a crucial regulator of osteoclast differentiation; its
absence reduced the number of mature osteoclasts, whereas
their bone-resorption activity did not appear to be affected.
Deletion of Tmem64 Exacerbates RANKL-Dependent
Ca2+ Oscillation and Mitochondrial ROS Generation
We next investigated the role of Tmem64 in the regulation of
RANKL-dependent signaling pathways, including ERK, p38,
JNK, NF-kB, and AKT, which are activated via the RANKL-
TRAF6-dependent axis (Kim et al., 2009). As shown in Figure 3A,
there was no significant difference in RANKL-dependent
activation between WT and Tmem64/ BMMs. Moreover, acti-
vation of the M-CSF-stimulated signaling pathways was also252 Cell Metabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inc.unchanged (Figure S3B). In contrast, ex-
pression levels of c-fos and NFATc1—
key regulators of osteoclast differentia-
tion—were decreased during osteoclast
formation in Tmem64/ BMMs (Fig-
ure 3B). CREB phosphorylation by
RANKL was significantly suppressed in
Tmem64/ BMMs without a substantial
change in protein expression (Figure 3B).As previously reported (Sato et al., 2006), CREB is critical for
RANKL-stimulated NFATc1 and c-fos induction in osteoclast
precursors. To investigate whether enforced expression of
CREB could rescue osteoclast formation in Tmem64/
BMMs, we used retroviruses to introduce CREB or a domi-
nant-negative inhibitor of CREB (A-CREB) into WT or
Tmem64/ BMMs. When CREB was introduced, the cells
underwent normal osteoclast differentiation accompanied by
significant induction of NFATc1 and c-fos (data not shown),
whereas introduction of A-CREB led to strong suppression of
osteoclast differentiation by RANKL (Figure 3C). These results
indicate that Tmem64 is required for RANKL-mediated CREB
activation during osteoclastogenesis.
RANKL-RANK signaling activates phospholipase Cg2 (PLCg2)
and leads to an increase in [Ca2+]i via ITAM-harboring molecules
DAP12 and FcRg, followed by activation of CaMKIV, which
mainly contributes to activation of CREB (Sato et al., 2006;
Takayanagi, 2007a; Wada et al., 2006). We examined whether
Tmem64 affects PLCg2 activation by RANKL stimulation (Fig-
ure 3D, upper panel) and found no differences between WT
and Tmem64/ activation of PLCg2 in BMMs, whereas CaMKIV
was barely activated in RANKL-stimulated Tmem64/ BMMs
Figure 3. Tmem64-Deficient BMMs Inhibits RANKL-Dependent Ca2+ Oscillation and Generation of Mitochondrial ROS
(A) RANKL-induced ERK, p38, JNK, IkB, and AKT phosphorylation in BMMs derived from WT and Tmem64/ mice.
(B) Activation of CREB and expression of c-fos, PGC1b (indicated with arrowhead) and NFATc1 during osteoclast differentiation.
(C) Rescue of osteoclastogenesis in Tmem64/ BMMs by CREB. Data are represented as mean ± SD.
(D) RANKL-induced PLCg2 and CaMKIV phosphorylation in WT and Tmem64/ BMMs.
(E) RANKL-induced oscillatory changes in [Ca2+]i concentration. Addition of 10 mM ionomycin at the end of each experiment is indicated by an arrow. Each color
indicates a different cell in the same field.
(F) RANKL-mediated mitochondrial ROS production in BMMs from WT and Tmem64/ mice. Data are expressed as relative MFI (%) ± SEM from three inde-
pendent experiments and histograms show one representative experiment.
(G) Retroviral Tmem64 introduction rescued RANKL-induced Ca2+ oscillations in Tmem64/ BMMs. Cells fromWT and Tmem64/mice were transduced with
empty or MSCV-Tmem64 retrovirus and then subjected to Ca2+ oscillation. The addition of 10 mM ionomycin at the end of each experiment is indicated by an
arrow.
(H) Retroviral Tmem64 rescued RANKL-inducedmitochondrial ROS generation in Tmem64/BMMs. Cells fromWT and Tmem64/mice were transducedwith
empty or MSCV-Tmem64 retrovirus and subjected to FACS analysis. Bar graph shows results of at least three independent experiments and histograms show
one representative experiment. *p < 0.01 between the indicated groups. See also Figure S3.
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Tmem64 regulates CaMKIV activation, we examined RANKL-
induced [Ca2+]i oscillation, which is important for CaMKIV
activation (Sato et al., 2006). As shown in Figure 3E, RANKL-Cell Minduced [Ca2+]i oscillation was impaired in BMMs derived from
Tmem64/ mice.
Because mitochondrial ROS produced downstream of
RANK and ITAM during osteoclastogenesis activate CREBetabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inc. 253
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affected the production of mitochondrial ROS by RANKL. Using
a mitochondrial ROS-specific dye (MitoSOX), we showed that
the production of mitochondrial ROS was substantially inhibited
in the absence of Tmem64 after stimulation by RANKL for 6 hr
(Figure 3F). Consistent with these data, PGC1b upregulation,
which follows mitochondrial ROS production and CREB activa-
tion, was suppressed (Figure 3B) (Ishii et al., 2009). In order to
verify the role of Tmem64, we infected Tmem64/ BMMs with
retroviral Tmem64 (MSCV-Tmem64). As expected, Ca2+ oscilla-
tion and mitochondrial ROS production were dramatically
enhanced by RANKL stimulation (Figures 3G and 3H); trans-
duced cells differentiated into mature osteoclasts (Figure S6B).
Thus, Tmem64 is required for proper [Ca2+]i oscillation and
optimal production of mitochondrial ROS induced by RANKL
during osteoclast differentiation.
Tmem64 Associates with SERCA2
When transfected into HEK293 cells, Tmem64 was mostly asso-
ciated with microsomal fractions containing endoplasmic retic-
ulum (data not shown). Therefore, to further investigate the
molecular mechanism of Tmem64, we immunoprecipitated the
microsomal fraction of HEK293T cells transfected with Flag-
tagged Tmem64 and identified the associated proteins by
Coomassie blue staining followed by mass spectrometry (Fig-
ure S4; Table S1). Interestingly, Tmem64 associated with
SERCA2, a protein essential for spiking Ca2+ oscillations (Mu¨ller
et al., 2006). To specifically determine the SERCA subtype that
mediated osteoclast differentiation, we performed real-time
PCR. As shown in Figure 4A, Atp2a2 (encoding SERCA2) was
strongly induced in comparison Atp2a3 (encoding SERCA3),
whereas Atp2a1 (encoding SERCA1) was not detected and there
was no difference in the expression of Atp2a2 and Atp2a3
between Tmem64/ and WT cells. Immunoblotting of total
proteins from RANKL+M-CSF-treated cells with an antibody
specific for SERCA2 revealed that it was highly upregulated
during osteoclast differentiation (Figure 4B). To confirm the
association between Tmem64 and SERCA2, we cotransfected
Myc-tagged SERCA2 and Flag-tagged Tmem64 into HEK293T
cells. Coimmunoprecipitation (coIP) showed that Tmem64 and
SERCA2 were strongly associated (Figure 4C). We then per-
formed coimmunolabeling and confocal microscopy to clarify
the subcellular localization of Tmem64 in HEK293T cells (Fig-
ure 4D). Confocal images indicated that Tmem64 colocalizes
with SERCA2 in the ER; calreticulin was used as an ER marker.
When retroviral Flag-tagged Tmem64 was reintroduced into
Tmem64/ BMMs, we found that endogenous SERCA2 copre-
cipitated with Tmem64-Flag from Tmem64-complemented
BMMs (Figure 4E). SERCA2 is a critical regulator of RANKL-
induced osteoclast formation by RANKL-mediated [Ca2+]i oscil-
lations in the NFATc1 pathway (Yang et al., 2009), raising the
possibility that suppression of SERCA2 activity may contribute
to the phosphorylation of CREB by RANKL. Thus, we examined
whether suppression of CREB phosphorylation impaired
[Ca2+]i oscillations in SERCA2 heterozygotes (SERCA2
+/). As
shown in Figure 4F, CREB activation was severely inhibited in
SERCA2+/; we also observed that osteoclast differentiation
was completely rescued by retroviral expression of CREB (Fig-
ure 4G). Consistent with these data, the production of mitochon-254 Cell Metabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Indrial ROS 6 hr after RANKL stimulation was suppressed in
SERCA2+/ cells (Figure 4H, left panel). We also confirmed that
Tmem64 siRNA repressed the generation of mitochondrial
ROS in SERCA2 WT cells (Figure 4H, right panel) and,
conversely, the retroviral expression of Tmem64 rescued osteo-
clast differentiation in SERCA2+/ cells (Figure 4I). These data
indicate that Tmem64 interaction with SERCA2 is critical in the
Ca2+ signaling cascade for RANKL-induced CREB activation
and mitochondrial ROS generation.
Tmem64 Modulates SERCA2 Activity by Association
with Its Regulatory C-Terminal Region during
Osteoclastogenesis
To gain insight into the SERCA activity critical for Ca2+ signaling
modulation by Tmem64, we measured intrinsic Ca2+-ATPase
activity, which represents SERCA activity (Randriamboavonjy
et al., 2008), in BMMs from WT and Tmem64/ mice using an
enzyme-coupled assay. As shown in Figure 5A, Ca2+-ATPase
activity was reduced by 60% in Tmem64/ BMMs versus
WT BMMs. Ionomycin, an intracellular calcium-elevating
compound, stimulates calcineurin/NFATc1 signal transduction
in BMMs, which leads to enhanced osteoclast differentiation.
These data indicate that both ER Ca2+ release and reuptake by
ER-process proteins, such as IP3Rs and SERCA, are critically
important to the Ca2+ signaling cascade. Consequently,
decreased Ca2+ concentrations in the ER trigger activation of
the store-operated Ca2+ entry (SOCE) pathway, thus activating
SERCA in the ER (Takayanagi, 2007b), but it was unclear
whether this occurred through increased activation or conduc-
tance of Ca2+ release channels, or from enhanced store filling.
To clarify the mechanism of activation, we examined whether
functional coordination of Ca2+ release and sequestration is
required for RANKL-dependent osteoclastogenesis. We used
a loss-of-function approach for SERCA2, employing thapsigar-
gin, a specific inhibitor of SERCA. As shown in Figure 5B, iono-
mycin-induced intracellular Ca2+ influx synergistically enhanced
TRAP+ MNC formation induced by RANKL; and this effect was
completely abolished by thapsigargin in WT cells without cyto-
toxicity (Figure S5A). In addition, ionomycin did not fully restore
the osteoclast differentiation defects in the absence of
Tmem64. Thus, modulation of SERCA2 activity by Tmem64
(and subsequent calcium uptake) is necessary for the RANKL-
induced osteoclast differentiation.
One remaining question was how Tmem64 regulates SERCA2
activity. One possible mechanism is through a direct interaction
with the regulatory region of SERCA2. The Camacho group
demonstrated that the intraluminal loop (L7–8) domain of
SERCA2 plays a critical role in the regulation of ER Ca2+ homeo-
stasis in Xenopus oocytes (Li and Camacho, 2004). Overexpres-
sion of ERp57 specifically inhibits SERCA2 activity through
association with the L7–8 domain of SERCA2. Based on this
observation, we hypothesized that Tmem64 binds and/or
modulates the L7–8 domain of SERCA2, which switches
SERCA2 to its active form. To investigate this hypothesis, we
generated deletion mutants of SERCA2 (Figure 5C) and looked
for binding to Tmem64. As shown in Figure 5D, in vitro deletion
mapping indicated that Tmem64 binds directly to the 257 amino
acid C-terminal segment of SERCA2, which contains the
L7–8 domain (SERCA2F2). Immunoprecipitation experimentsc.
Figure 4. Tmem64 Modulates CREB Phosphorylation and Mitochondrial ROS Generation through Association with SERCA2
(A) Expression of SERCA isotypes during osteoclast differentiation.
(B) Expression of SERCA2 during osteoclast differentiation in WT and Tmem64/ BMMs.
(C) Physical association between Tmem64 and SERCA2. HEK293T cells were transfected with indicated vectors. Flag or Myc immunoprecipitates were
immunoblotted with anti-Flag or anti-Myc to visualize.
(D) Immunohistochemistry of Tmem64 and SERCA2. HEK293T cells were cotransfected with Flag-Tmem64 and Myc-SERCA2, and calreticulin was used as an
ER marker.
(E) Tmem64/BMMswere transduced with the Flag-tagged Tmem64. Cell lysates were prepared and subjected to IP with anti-Flag or anti-SERCA2 antibodies,
and immunoblotted with indicated antibodies.
(F) Western blot analysis of phospho-CREB and NFATc1 expression in BMMs and osteoclasts.
(G) Osteoclast differentiation rescued by retroviral expression of CREB in SERCA2+/ BMMs. Data are represented as mean ± SD.
(H) RANKL-induced mitochondrial ROS generation in BMMs from WT and SERCA2+/ mice (left panel) and Tmem64 siRNA suppressed mitochondrial ROS
production (right panel). Data are expressed as relativeMFI (%) ± SEM from three independent experiments and histograms show one representative experiment.
(I) Osteoclast differentiation rescued by retroviral expression of Tmem64 in SERCA2+/ BMMs. Data are represented as mean ± SD *p < 0.01 between the
indicated groups. See also Figure S4.
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segment, did not bind to Tmem64-Flag. Further evaluation of
the specificity of the Tmem64-SERCA2 association was ad-
dressed in competition assays using ERp57, which ismoderately
expressed during osteoclast differentiation without substantialCell Mchanges in Tmem64/ versus WT cells (Figure S5B). We
confirmed the association between the SERCA2 C terminus
region and ERp57 (Figure S5C). As shown in Figure 5E, recip-
rocal coimmunoprecipitation performed using Tmem64-Flag
and SERCA2-Myc, in addition to increasing the amount ofetabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inc. 255
Figure 5. Tmem64 Modulates RANKL-Stimulated Ca2+ Signal via Interaction with SERCA2 C Terminus Region
(A) Comparison of Ca2+-ATPase activity from WT and Tmem64/ BMMs. Details are described in Experimental Procedures.
(B) Induction of Ca2+ by ionomycin only partially rescued osteoclast differentiation of Tmem64/ BMMs. BMMs were cultured with thapsigargin (5nM) and
ionomycin (0.5 mM) for 3 days with medium containing M-CSF and RANKL.
(C) Schematic representation of SERCA2 and the series of SERCA2 deletion constructs.
(D) Tmem64 interacts with the SERCA2 C terminus. Flag-tagged Tmem64 coimmunoprecipitates with the Myc-tagged SERCA2 deletion series. HEK293T cells
were transfected as indicated with Tmem64-Flag, SERCA2-Myc, SERCA2F1-Myc, and SERCA2F2-Myc. Cells were lysed and Tmem64was immunoprecipitated
with anti-Flag antibody. Coimmunoprecipitated SERCA2 was detected by anti-Myc antibody; *nonspecific band.
(E) Competitive interaction between Tmem64 and ERp57. HEK293T cells were transfected with a constant amount (1 mg) of pcDNA3.1-Tmem64-Flag and
pcDNA3.1-SERCA2-Myc and increasing amounts (0, 0.1, 0.2, 0.5, and 1 mg) of pcDNA3.1-ERp57-HA; empty vector was added to ensure a similar amount of DNA
was transfected in each sample. After 24 hr, cell lysates were incubated with Flag and HA-affinity agarose gel beads and western blotted with the indicated
antibodies.
(F) Retroviral Tmem64 introduction rescued Ca2+-ATPase activity in Tmem64/ BMMs. *p < 0.01 between the indicated groups. Data are represented as
mean ± SD. See also Figure S5.
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SERCA2 is reduced by ERp57 in a dose-dependent manner,
and that Tmem64 association with the L7–8 domain in the C
terminus region of SERCA2 was required for SERCA2 Ca2+
pump activation. Consistently, we also showed that ERp57
inhibited CREB phosphorylation and suppressed osteoclast256 Cell Metabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Indifferentiation (Figures S5D and S5E). Finally, to explore the
relevance of our results to the modulation of SERCA2
activity, we examined whether Tmem64 is required for
SERCA2 activation. As shown in Figure 5F, the activity of
Ca2+-ATPase was fully recovered in MSCV-Tmem64-introduced
Tmem64/ BMMs. Taken together, the results demonstratec.
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mediates RANKL-dependent Ca2+ signaling during osteoclast
differentiation.
DISCUSSION
Osteoclasts are highly specialized, multinucleated cells that
tightly regulate skeletal homeostasis. They are differentiated
from hematopoietic stem cells by macrophage colony-stimu-
lating factor (M-CSF, also known as Csf1), which stimulates
the proliferation and survival of osteoclast precursor cells and
RANKL (also known as TNFSF11), a key cytokine for osteoclas-
togenesis and a member of the tumor necrosis factor (TNF)
family. Recent studies have determined the function of NFATc1,
which is induced by RANKL and plays a crucial role in differen-
tiation, fusion, maturation, activation, and survival of osteoclasts
(Ferron et al., 2011; Kim et al., 2008; Takayanagi, 2007b;
Takayanagi et al., 2002). Transcription of NFATc1 is mainly regu-
lated by Ca2+ signals, which are activated by costimulatory
signaling via FcRg and DAP12. Although the mechanism has
not been clearly elucidated in osteoclasts, Ca2+ oscillation
induced by RANKL is thought to be important for efficient acti-
vation of NFATc1 via the Ca2+-dependent phosphatase
calcineurin, which lies downstream of FcRg and DAP12. After
Ca2+ stimulation, activated NFATc1 has a short half-life. Thus,
a ‘‘cycling hit’’ such as continuous Ca2+ spiking is required
for long-lasting transcriptional activation of NFATc1 during
osteoclastogenesis (Negishi-Koga and Takayanagi, 2009;
Yang and Li, 2007). A Ca2+ cycling hit requires tight regulation
of the reduction and refilling of ER Ca2+ stores. IP3-mediated
signaling has an IP3R2- and IP3R3-dependent physiological
role in ER Ca2+ release during osteoclast differentiation
(Kuroda et al., 2008). Recently, it has been reported to regulate
Ca2+ entry processes during osteoclastogenesis by plasma
membrane-localized Ca2+-permeable channels, such as Orai1
and TRPV4 (Masuyama et al., 2008; Robinson et al., 2012).
However, the mechanisms or molecules involved in Ca2+ reup-
take into ER stores by RANKL-dependent Ca2+ signaling
are largely unknown. Here, we determined that ablation of
Tmem64 impaired osteoclast differentiation, causing strong
suppression of RANKL-triggered CREB activation and c-fos
and NFATc1 induction. Further, Tmem64/ BMMs exhibited
attenuated RANKL-induced Ca2+ oscillations. Consistent with
these data, introduction of CREB, c-fos, or Tmem64 into
Tmem64/ BMMs were sufficient to rescue osteoclastogene-
sis (Figures 3C and S6).
Tmem64 has seven predicted transmembrane domains and
a conserved SNARE domain by TMPRED program analysis,
but its function has been completely unknown. In this study,
we showed that Tmem64 is associated mainly with ER. Intrigu-
ingly, in vitro pull-down assays and coimmunoprecipitation anal-
yses revealed that Tmem64 associates with SERCA2, which
impairs Ca2+ oscillations and leads to defective osteoclast differ-
entiation in heterozygotes. Furthermore, we provide mechanistic
clarification of both the suppression of CREB phosphorylation
and the downregulation of NFATc1 during osteoclastogenesis
(Figure 4F). Indeed, we observed decreased SERCA2 activity
(by 60%) in Tmem64/ BMMs compared with WT cells.
However, it is not known how SERCA2 regulates intracellularCell MCa2+ homeostasis for Ca2+ oscillations during osteoclastogene-
sis. We found that Tmem64 specifically associated with the L7–8
domain of SERCA2 (SERCA2F2) by competing with ERp57,
which is necessary for Ca2+ oscillations, whereas Tmem64 is
required for their activation. Posttranslational modifications,
such as SUMOylation, are critical regulators of protein function
and play an important role in various cellular processes (Geiss-
Friedlander and Melchior, 2007). Kho et al. (2011) determined
that SERCA2a function is regulated by SUMO1-dependent
modulation in heart failure. SUMOylation of SERCA2a elevated
its stability and activity, thereby improving heart function. We
also identified E3 SUMO-protein ligase RanBP2 as a Tmem64-
associated factor via coimmunoprecipitation (Table S1). RanBP2
binds Ubc9 and SUMO1 and enhances SUMOylation of HDAC4,
Sp100, and PML (Kirsh et al., 2002; Wilkinson and Henley, 2010);
however, the relationship between Tmem64, SERCA2, and
RanBP2 requires further investigation.
One of the most noteworthy findings of this study is that
RANKL-induced Ca2+ signaling is dependent on SERCA2
activity, which is critically mediated by Tmem64. Our study
provides important insight into the coordinated mechanism of
SOCE and Ca2+ release-activated Ca2+ (CRAC) channels in
osteoclasts. Furthermore, significant suppression of SERCA2
activity by RANKL correlated with the generation of mitochon-
drial ROS. Involvement of mitochondrial ROS in NFATc1 induc-
tion has been clearly demonstrated (Ishii et al., 2009; Ke et al.,
2006). However, these data are subject to different interpreta-
tions with respect to the cause-effect relationship between
Ca2+ signaling and mitochondrial ROS generation by RANKL.
Our study shows that Ca2+ oscillations lead to the production
of mitochondrial ROS, which is reversed by full-length Tmem64
(Figures 3G and 3H).
Interestingly we also showed that cyclosporin A treatment
significantly inhibited RANKL-induced Tmem64 mRNA expres-
sion (Figure S3C), suggesting that NFATc1 is mediating the
upregulation of Tmem64 mRNA expression during osteoclast
differentiation. Taken together with its importance to Ca2+
oscillation/NFATc1 activation, Tmem64 is likely to control the
positive feedback controlled regulation of NFATc1-mediated
osteoclastogenesis.
Although not studied in detail here, the effect of Tmem64 on
osteoblasts appears to be cell-intrinsic, as shown in calvarial
or bone marrow stromal cells cultured in osteogenic media.
However, the detailed mechanism of how Tmem64 regulates
osteoblast differentiation needs future study. Moreover,
althoughwe clearly showed that there was decreased osteoclast
activity and increased osteoblast activity in Tmem64/ mice,
and Tmem64 has a cell-intrinsic role in both cell types, it is not
clear in which cell type Tmem64 is more important to the
Tmem64/ bone volume phenotype. This will require future
studies involving cell-type-specific deletion of Tmem64.
In summary, our study suggests that Tmem64 in the ER of
BMMs contributes to the efficient activation of SERCA2 (Fig-
ure 6). Impairment of Ca2+ signaling pathways in the absence
of Tmem64 reduces SERCA2 activity and mitochondrial ROS
production, resulting in inefficient osteoclast differentiation and
function. Identification and elucidation of key mediators of
Ca2+ oscillation by RANKL should aid in the development of
therapeutic strategies for the treatment of skeletal diseases.etabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inc. 257
Figure 6. Schematic Model Depicting the Role of Tmem64-Mediated
Ca2+ Oscillation in Production of Mitochondrial ROS during OC
Differentiation
Shown are mechanisms that involve the RANKL-stimulated Ca2+ signal
pathway. Association between Tmem64 and SERCA2 in the ER leads to
cytosolic Ca2+ spiking for activation of NFATc1 and production of mitochon-
drial ROS, thereby triggering a Ca2+ signaling cascades that promote osteo-
clast differentiation and activation.
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Animals and Materials
For Tmem64-deficient mice, a mouse embryonic stem cell line (SYA242, stain
129P2/OlaHsd) with an insertional mutation in Tmem64 was obtained from
BayGenomics (Stryke et al., 2003) through the International Gene Trap
Consortium (Nord et al., 2006; Skarnes et al., 2004). The gene-trapping vector,
pGT01xf, was designed to introduce an in-frame fusion between the 50 exons
of the trapped gene and a reporter, b-geo (a fusion of b-galactosidase and
neomycin phosphotransferase II). To determine the location of the genomic
insertion site in the SYA242 stem cell line, genomic DNA was extracted from
the embryonic stem cells by using the DNeasy blood and tissue kit (QIAGEN).
PCR was then performed using primers P1 (within intron 2–3 of Tmem64,
50-AGTCCATCGCGCTCAAGTGG-30) and P3 (within the b-geo gene of
the gene-trapping vector, 50-AGTATCGGCCTCAGGAAGATCG-30), and the
PCR product was sequenced to verify the insertion site. The embryonic
stem cells were injected into C57BL/6 blastocysts to create chimeric mice,
which were bred with C57BL/6 mice to generate heterozygous Tmem64-
deficient mice. The heterozygous mice were interbred to generate all
Tmem64-deficient genotypes. Primers P1, P2 (50-GCATGCACTGTAGAC
CAGGTGC-30), and P3 were used for multiplex genotyping thereof all three
genotypes (+/+, +/,/). The generation of SERCA2+/mice was previously
reported by our group (Prasad et al., 2005). We used 6- to 8-week-old male
mice, and all animal work was performed with veterinary supervision in an
accredited facility using protocols approved by the Animal Care and Use
Committee of the University of Pennsylvania. All other reagents were acquired
from Sigma.
Microcomputed Tomography, Histological Analysis,
and Measurement of Mineral Deposition Rate
Microcomputed tomography, histological analysis, and measurement of
mineral deposition rate were performed as previously described. For details,
see the Supplemental Experimental Procedures (Lee et al., 2006).
Osteoclast Differentiation
Bone marrow-derived macrophages (BMMs) were obtained from cultures of
bone marrow collected from 6- to 8-week-old male tibias and femurs as
described (Song et al., 2012). Cells were cultured for 3 days in a-MEM contain-
ing M-CSF (60 ng/ml) and RANKL (150 ng/ml). After culture for 3 days, the cells
were fixed with 3.7% formaldehyde in PBS for 10 min and stained for TRAP
using the acid phosphatase, leukocyte (TRAP) kit (Sigma). TRAP-positive
multinucleated cells containing three or more nuclei and an actin ring were
counted. To analyze bone pit formation, BMMs (1 3 104 cells/well in 96-well
plates) were seeded onto dentine slices and allowed to differentiate into oste-
oclasts in the presence of M-CSF and RANKL for 5 days, with a change of
medium after 2 days. Cells on the dentin slice were removed by washing258 Cell Metabolism 17, 249–260, February 5, 2013 ª2013 Elsevier Inwith PBS, and stained with 1% toluidine blue (Sigma-Aldrich); pit formation
was analyzed using the VIA-160 video image-maker measurement system
(Boeckeler Instruments).
Osteoclast Proliferation and Apoptosis Assay
Proliferation was measured by absorbance at 450 nm by using the BrdU Cell
Proliferation Assay Kit (Cell Signaling) according to the manufacturer’s
protocol. Osteoclast apoptosis was assayed as previously described (Kim
et al., 2009). Briefly, purified osteoclasts were cultured without RANKL for
9 hr and then measured with a caspase-3 colorimetric assay kit (R&D
Systems).
Mitochondrial ROS Measurement
ROS were measured by flow cytometry using the MitoSOX Red mitochondrial
superoxide indicator. Cells were treated as indicated, stained with 5 mM
MitoSOX Red for 10 min, and washed with media three times for 2 min per
wash. Cells were detached with enzyme-free cell dissociation solution
(Millipore, Bedford, MA). Detached cells were washed once with PBS and
resuspended in PBS containing 2% FBS and 0.7 mM EDTA (disodium salt).
Fluorescence was recorded on the PE channel (excitation 510 nm,
emission 580 nm) of a FACSCalibur (BD Biosciences, Heidelberg, Germany).
For each analysis, 1 3 104 cells were counted. Mean values of the log
fluorescence in individual samples were recorded and normalized to control
cells.
SERCA2 Activity
SERCA2 activity was measured with an enzyme-coupled assay according to
previously described methods (Randriamboavonjy et al., 2008).
[Ca2+]i Oscillation
A total of 53 104 BMM cells were seeded on the coverslips in the bottom of a
24-well plate and cultured with RANKL (150 ng/ml) in the presence of
M-CSF (60 ng/ml) for 48 hr. Cells were then incubated in the presence of
5 mM fluo-4 AM, 10 mM Fura Red AM, and 0.05% Pluronic F-127 (Invitrogen)
for 30 min in serum and phenol red-free a-MEM (Invitrogen). Cells were
washed twice with a-MEM and postincubated in a-MEM with 10% FBS, and
10 ng/ml RANKL for 20 min. The dye-loaded cells were washed twice with
a-MEM and Hank’s buffered salt solution. Cells were viewed on the inverted
stage of a confocal microscope (Leica). The loading medium consisted of
115 mM NaCl, 20 mM HEPES-NaOH, 5.4 mM KCl, 1 mM MgCl2, 2 mM
CaCl2, and 10 mM glucose (pH 7.4). At an excitation wavelength of 488 nm,
emission at 493–539 nm for fluo-4 and 653–742 nm for Fura Red was analyzed
simultaneously at 5 s intervals. The ratio of fluo-4 to Fura Red was calculated
to estimate intracellular Ca2+ influx concentrations in single cells (Sato et al.,
2006).
Statistical Analysis
Data were analyzed be using Student’s two-tailed t test and are presented as
mean ± SEM or ± SD, as indicated. Means were checked for statistical
differences using the Student’s t test with error probabilities of *p < 0.01 and
**p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
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